Page last updated: 2024-08-22

nitroxoline and Carcinoma, Transitional Cell

nitroxoline has been researched along with Carcinoma, Transitional Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Araki, M; Huang, P; Lin, W; Liu, C; Nasu, Y; Sadahira, T; Sun, J; Wada, K; Watanabe, M; Xu, A; Xu, N	1

Other Studies

1 other study(ies) available for nitroxoline and Carcinoma, Transitional Cell

Article	Year
Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer. International journal of biological sciences, 2021, Volume: 17, Issue:12 Topics: Animals; Anti-Infective Agents, Urinary; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carcinoma, Transitional Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroquinolines; Signal Transduction; STAT3 Transcription Factor; Urinary Bladder Neoplasms	2021

Article

Year

Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.

International journal of biological sciences, 2021, Volume: 17, Issue:12

Topics: Animals; Anti-Infective Agents, Urinary; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carcinoma, Transitional Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroquinolines; Signal Transduction; STAT3 Transcription Factor; Urinary Bladder Neoplasms

2021